United Kingdom glucometers market is anticipated to witness a growth of steady CAGR in the forecast period, 2023-2027. The market is driven by the rise in the prevalence of diabetes, unhealthy eating habits, obesity, and increased level of physical inactivity. Also, the high disposable income and surge in awareness about the preventive healthcare benefits are the other factors that are expected to play a major role in accelerating the growth of the United Kingdom glucometer market.
Increased Prevalence of Diabetes Drives the Market Growth
There are more than a million people diagnosed with Diabetes in the United Kingdom, and this number is growing at a rapid rate. Currently, Diabetes is considered one of the major challenges faced by the United Kingdom healthcare sector. It has been found that more than 4.9 million people have Diabetes, and 13.6 million people are at increased risk of type 2 diabetes in the United Kingdom. Diabetes is adversely affecting the current lifestyle and health conditions of the patients. Diabetes is among the leading causes of preventable sight loss in the country, and more than 1,700 people's sight gets seriously affected by Diabetes every year. And more than 700 people who have Diabetes die prematurely every week. Patients are becoming more aware and are actively buying devices that can instantly tell the sugar level to take preventive measures.
The rise in the awareness among the patients about the side-effects of Diabetes and the high prevalence of Diabetes is expected to accelerate the growth of the United Kingdom glucometers market in the next five years.
Increased Government Funding on Healthcare Infrastructure Fuels Market Growth
The government is allocating massive funds for the development of the healthcare sector of the country. The National Health Service spends at least £10 billion every year, accounting for 10% of the entire budget. They also support research and development activities and new product and drug development to lower the number of patients who have various diabetes across the United Kingdom. The government of the United Kingdom has taken the initiative and formed the ‘National Service Framework for Diabetes’ to set standards for diabetes care. It aims to improve care for people who are suffering from diabetes and improve the quality of services offered to patients in England. It supports the development of diabetes clinics to bring together a set of specialist expertise and services, including eye screening and foot care. The forum also aims to help the patients to manage their insulin levels around their lifestyle.
Furthermore, if the patient is using insulin or medicine to manage diabetes, he/she is entitled to free prescriptions. If the patient is below 60 and a resident of England, he/she must have a medical exemption certificate before claiming the money. And the prescriptions are free for patients in Wales, Scotland, and Northern Ireland.
Click here to download the sample
Market Segmentation
The United Kingdom glucometers market is segmented into product type, technique, type, distribution channel, end user, regional distribution, and competitive landscape. Based on product type, the market is divided into self glucose monitoring glucometers and continuous glucose monitoring glucometers. Based on technique, the market is bifurcated into invasive and non-invasive. Based on type, the market is bifurcated into wearable and non-wearable. Based on distribution channel, the market is divided into hospital pharmacies, retail outlet, online, and others. Based on end user, the market is divided into hospitals & clinics, diagnostic centers, home care, others. The United Kingdom glucometers market is studied in major regions namely London, Southeast, East Anglia, Scotland, Southwest, East Midlands, Yorkshire & Humberside, and Rest of United Kingdom.
Market Players
Abbott Laboratories Limited, Medtronic United Kingdom, Roche Diagnostics Limited, Dexcom United Kingdom, Dr.Morpen, are the major market players operating in the United Kingdom glucometers market.
| Attribute | Details |
| Base Year | 2021 |
| Historic Data | 2017 – 2020 |
| Estimated Year | 2022 |
| Forecast Period | 2023 – 2027 |
| Quantitative Units | Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027 |
| Report coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
| Segments covered | · Product Type · Technique · Type · Distribution Channel · End User |
| Regional scope | London, Southeast, East Anglia, Scotland, Southwest, East Midlands, Yorkshire & Humberside, Rest of United Kingdom |
| Key companies profiled | Abbott Laboratories Limited, Medtronic United Kingdom, Roche Diagnostics Limited, Dexcom United Kingdom, Dr.Morpen |
| Customization scope | 10% free report customization with purchase. Addition or alteration to regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
